Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
For the first time in the 30-year battle against the HIV epidemic, a panel of experts has recommended that the Food and Drug Administration approve a drug to give to healthy people to protect against the infection.
A panel of US health experts has for the first time backed a drug to prevent HIV infection in healthy people.
History was made Thursday evening as an FDA panel recommended approval of a drug that could prevent the spread of HIV, the virus that causes AIDS -- a disease that has killed 30 million people around the world.
The first annual gala for the Gladstone Institutes raises awareness of its mission “to unravel the basics of biology in order to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease.”
Gladstone investigator Li Gan is quoted in this article about recent studies indicating that abnormal protein deposits in brain cells may contribute to frontotemporal degeneration.
Scientists at the Gladstone Institutes have determined how specific circuitry in the brain controls not only body movement, but also motivation and learning, providing new insight into neurodegenerative disorders such as Parkinson’s disease — and psychiatric disorders such as addiction and depression.
Gladstone's Dr. Robert Grant proved more than a year ago that gay men who were HIV negative could substantially decrease their risk of contracting the AIDS virus by taking the antiretroviral drugs otherwise used for treatment. The same arguably might be accomplished by heterosexuals.
AIDS researcher Robert Grant is named in the top 100 because of his work at the Gladstone Institute of Virology and Immunology.
Researchers have declared a research breakthrough in mice that shows promise to restore hearts damaged by heart attacks -- by converting scar-forming cardiac cells into beating heart muscle
Millennium Technology Prize Laureate Shinya Yamanaka - In recognition of his discovery of a new method to develop induced pluripotent stem cells for medical research that do not rely on the use of embryonic stem cells.